Literature DB >> 29563993

Flattening filter-free technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy: A clinical comparison with the flattening filter technique.

Shuri Aoki1, Hideomi Yamashita1, Akihiro Haga1, Kanabu Nawa1, Toshikazu Imae1, Wataru Takahashi1, Osamu Abe1, Keiichi Nakagawa1.   

Abstract

The present study sought to evaluate the impact of the flattening filter-free (FFF) technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy. Its clinical safety and availability were compared with the flattening filter (FF) method. The cases of 65 patients who underwent lung volumetric modulated arc therapy-stereotactic body radiotherapy (VMAT-SBRT) using FF or FFF techniques were reviewed. A total of 55 Gy/4 fractions (fr) was prescribed for peripheral lesions or 56 Gy/7 fr for central lesions. The total monitor units (MU), treatment time, dose to tumors, dose to organs at risk, tumor control (local control rate, overall survival, progression-free survival) and adverse events between cases treated with FF and cases treated with the FFF technique were compared. A total of 35 patients were treated with conventional FF techniques prior to November 2014 and 30 patients were treated with FFF techniques after this date. It was revealed that the beam-on time was significantly shortened by the FFF technique (P<0.01). Other factors were similar for FFF and FF plans in respect to conformity (P=0.95), homogeneity (P=0.20) and other dosimetric values, including total MU and planning target volume/internal target volume coverage. The median follow-up period was 18 months (range, 2-35). One-year local control rates were 97.1 and 90.0% in the FF group and FFF groups, respectively (P=0.33). Grade 3 pneumonitis was observed in 5.8% of FF patients and 3.4% of FFF patients (P=1.00). No other adverse events ≥grade 3 were observed. The results of the study suggest that VMAT-SBRT using the FFF technique shortens the treatment time for lung SBRT while maintaining a high local control rate with low toxicity.

Entities:  

Keywords:  flattening filter-free; lung cancer; radiation pneumonitis; stereotactic body radiotherapy; volumetric modulated arc therapy

Year:  2018        PMID: 29563993      PMCID: PMC5854932          DOI: 10.3892/ol.2018.7809

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  41 in total

1.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

2.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

Review 3.  Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer.

Authors:  Genevieve Maquilan; Robert Timmerman
Journal:  Cancer J       Date:  2016 Jul-Aug       Impact factor: 3.360

Review 4.  Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non-Small-cell Lung Cancer: A Systematic Review.

Authors:  Conrad B Falkson; Emily T Vella; Edward Yu; Medhat El-Mallah; Robert Mackenzie; Peter M Ellis; Yee C Ung
Journal:  Clin Lung Cancer       Date:  2016-10-27       Impact factor: 4.785

5.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

6.  Stereotactic Body Radiotherapy Results for Pulmonary Oligometastases: A Two-Institution Collaborative Investigation.

Authors:  Yuzuru Niibe; Hideomi Yamashita; Kenji Sekiguchi; Wataru Takahashi; Kenshiro Shiraishi; Kae Okuma; Atsuro Terahara; Jiro Kawamori; Keiichi Nakagawa
Journal:  Anticancer Res       Date:  2015-09       Impact factor: 2.480

7.  Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.

Authors:  Wataru Takahashi; Hideomi Yamashita; Satoshi Kida; Yoshitaka Masutani; Akira Sakumi; Kuni Ohtomo; Keiichi Nakagawa; Akihiro Haga
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-04-05       Impact factor: 7.038

8.  Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.

Authors:  Ronica H Nanda; Yuan Liu; Theresa W Gillespie; John L Mikell; Suresh S Ramalingam; Felix G Fernandez; Walter J Curran; Joseph Lipscomb; Kristin A Higgins
Journal:  Cancer       Date:  2015-09-08       Impact factor: 6.860

9.  Effects of flattening filter-free and volumetric-modulated arc therapy delivery on treatment efficiency.

Authors:  Evan M Thomas; Richard A Popple; Brendan M Prendergast; Grant M Clark; Michael C Dobelbower; John B Fiveash
Journal:  J Appl Clin Med Phys       Date:  2013-11-04       Impact factor: 2.102

10.  Novel insights of oligometastases and oligo-recurrence and review of the literature.

Authors:  Yuzuru Niibe; Joe Y Chang
Journal:  Pulm Med       Date:  2012-08-22
View more
  4 in total

1.  Surface and build-up dose comparison between Elekta 6 MV flattening filter and flattening-filter-free beams using an advanced Markus ionization chamber and a solid water-equivalent phantom.

Authors:  Toshikazu Imae; Shigeharu Takenaka; Yuichi Watanabe; Atsushi Aoki; Kanako Matsuda; Katsutake Sasaki; Shigeki Saegusa; Kanabu Nawa; Keiichi Nakagawa; Osamu Abe
Journal:  J Appl Clin Med Phys       Date:  2020-11-12       Impact factor: 2.102

2.  Impact of Dosimetric Parameters on Interplay Effects in 6 MV Flattening Filter-Free Photon Beams to Treat Lung Cancer.

Authors:  Vanida Poolnapol; Taweap Sanghangthum; Mintra Keawsamur
Journal:  J Med Phys       Date:  2022-03-31

3.  Flattening filter free stereotactic body radiation therapy for lung tumors: outcomes and predictive factors.

Authors:  Thitiporn Jaruthien; Sarin Kitpanit; Danita Kannarunimit; Chonnipa Nantavithya; Anussara Prayongrat; Petch Alisanant; Kitwadee Saksornchai; Napapat Amornwichet; Tassapong Raiyava; Chakkapong Chakkabat; Chawalit Lertbutsayanukul; Chonlakiet Khorprasert; Kanjana Shotelersuk
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

Review 4.  Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review.

Authors:  Shuri Aoki; Hideomi Yamashita; Osamu Abe; Keiichi Nakagawa
Journal:  Transl Cancer Res       Date:  2020-08       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.